Neurofibromatosis | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Regulatory

4 February 2025

The month ahead: February’s upcoming events

Approval decisions await Ono and SpringWorks, while key data approach for Pfizer and Arvinas’s SERD.

Subscribe to Neurofibromatosis